by admin | Nov 5, 2023 | blog
In the rapidly evolving world of medical technology, Cancilico recently had the opportunity to attend the prestigious “AI-in-Medicine” conference, a gathering that showcases the latest advancements and discussions in the field of artificial intelligence in...
by admin | May 20, 2023 | blog
The recent years have brought a lot of advancements in understanding leukemia biology due to comprehensive studies investigating molecular alterations. Risk stratification, however, is still largely restricted to simplistic decision-making models based on singular...
by admin | Apr 5, 2023 | blog
Achievement of complete remission signifies a crucial milestone in the therapy of acute myeloid leukemia (AML) while refractory disease is associated with dismal outcomes. Hence, accurately identifying patients at risk is essential to tailor treatment concepts...
